Paul Emery (academic)

Paul Emery FRCPE FMedSci MACR OBE is a British rheumatologist, researcher, and academic. Emery has been the Versus Arthritis Professor of Rheumatology at the University of Leeds since 1995,[lower-alpha 9] Head of its Rheumatology Department Since 2018. He is Head of the Academic Unit of Musculoskeletal Disease and Lead Clinician of Rheumatology at the Leeds Teaching Hospital NHS Trust, and was the Director of the NIHR Leeds Biomedical Research Centre from 2009 to 2022. Emery played a critical role in bringing sensitive imaging (MRI) into rheumatology practice. He is known for introducing early intervention in inflammatory arthritis. In 2012, Emery was awarded the Carol Nachman Prize for Rheumatology,[2] and as of 2023, he has published over 1250 peer-reviewed articles.[3][4][5][6]

Prof.

Paul Emery

OBE FRCPE FMedSci FLSW MACR
NationalityUnited Kingdom
EducationCardiff High School[lower-alpha 1], Churchill College, Cambridge
Occupation(s)Rheumatologist, researcher, academic
Years active1977–present[1]
Medical career
Profession
  • Versus Arthritis Professor of Rheumatology (Leeds), Head of Rheumatology Department (Leeds)
  • 1995-2017 Director (NIHR Leeds Biomedical Research Centre) 2008-2022
  • Head of Academic Unit of Musculoskeletal Disease and Lead Clinician of Rheumatology (Leeds Teaching Hospital Trust) 1994-2017
[1]
Institutions
  • Guy’s Hospital/Brompton Hospital (1977-1980)
  • Guy’s/Brighton/Lewisham 1980-1985
  • Walter & Eliza Hall Institute (1985-1987)[lower-alpha 2]
  • Royal Melbourne Hospital (1985-1987)
  • University of Birmingham (1988-1995)[lower-alpha 3]
  • University of Leeds (1995-present)[lower-alpha 4]
  • Leeds Teaching Hospital Trust (1997-2022)[lower-alpha 5][1]
Awards
  • Roche Biennial Award for Clinical Rheumatology (1991)
  • Hospital Doctor of the Year Rheumatology (1999)
  • EULAR Prize for outstanding contribution to Rheumatology (2002)
  • NIHR Senior Investigator NMR (2009)
  • Carol Nachman Prize for Rheumatology (2012)[lower-alpha 6]
  • The World’s Most Influential Scientific Minds (2015)
  • Highly Cited Researcher in Clinical Medicine (2015)[lower-alpha 7]
  • Highly Cited Researcher (2017)[lower-alpha 8]
  • OBE (2018)
  • Master of the American College of Rheumatology (2018)
  • Meritorious Service Award from EULAR (2020)
Academic work
Main interestsRheumatoid arthritis (RA), psoriatic arthritis (PsA), psoriatic disease, connective tissue diseases, prevention of autoimmune diseases, factors leading to persistent inflammation, Scleroderma, Sjogren Syndrome, immunopathogenesis, immunotherapy, disease prevention, ultrasound, MRI imaging

Early life and education

Emery graduated from Churchill College, Cambridge in 1974. He received his clinical training at Guy's Hospital and his speciality training at Royal Brompton Hospital where he was accredited in rheumatology and general internal medicine in 1984.[4]

Career

Emery worked at Guys Hospital from 1977 to 1985.

In 1985 Emery became Head of Rheumatology at the Walter and Eliza Hall Institute, and a consultant at the Royal Melbourne Hospital.

In 1988 Emery became a Senior Lecturer at the University of Birmingham.

Emery has been the Arthritis Research UK Professor of Rheumatology at the University of Leeds since 1995.

Emery was inaugural President of the International extremity MRI society (ISEMIR).[5]

Emery has been a senior investigator at the National Institute for Health and Care Research since 2008.[5]

From 2009 to 2011 Emery presided the European Alliance of Associations for Rheumatology (EULAR).

In 2010 he ranked first as the most cited European Rheumatologist with 16,952 citations, according to Lab Times.[7][8]

In 2013 Boyack et al. published "A list of highly influential biomedical researchers, 1996–2011." in the European Journal of Clinical Investigation. They selected Emery among 532 authors who belonged to the 400 researchers with highest total citation count (25,142 or more citations).[9]

Emery was an inaugural chair of FOREUM Executive, the Foundation for Research in Rheumatology, from 2013 to 2019.[10]

In 2015, Emery was elected a Fellow of the Academy of Medical Sciences.[11]

In 2017 Emery ranked first as the most cited European Rheumatologist with 20,223 citations, according to Lab Times.[12][13]

In 2018 Emery was awarded an Order of the British Empire (OBE) by the Queen.[14]

In 2021 Emery became a Fellow of the Learned Society of Wales (FLSW).[15]

Bibliography

Books
  • Rheumatoid Arthritis: An Overview (2008) ISBN 9789814206464
  • Pocket Reference to Early Rheumatoid Arthritis (2011) ISBN 9781908517227
  • Atlas of Rheumatoid Arthritis (2015) ISBN 9781907673917

Select publications
  • Maini, Ravinder, E. William St Clair, Ferdinand Breedveld, Daniel Furst, Joachim Kalden, Michael Weisman, Josef Smolen et al. "Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial." The Lancet 354, no. 9194 (1999): 1932–1939. doi:10.1016/S0140-6736(99)05246-0
  • Lipsky, Peter E., Desiree MFM van der Heijde, E. William St. Clair, Daniel E. Furst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S. Smolen et al. "Infliximab and methotrexate in the treatment of rheumatoid arthritis." New England Journal of Medicine 343, no. 22 (2000): 1594–1602. doi:10.1056/NEJM200011303432202
  • Edwards, Jonathan CW, Leszek Szczepański, Jacek Szechiński, Anna Filipowicz-Sosnowska, Paul Emery, David R. Close, Randall M. Stevens, and Tim Shaw. "Efficacy of B-cell–targeted therapy with rituximab in patients with rheumatoid arthritis." New England Journal of Medicine 350, no. 25 (2004): 2572–2581. doi:10.1056/NEJMoa032534
  • Cohen, Stanley B., Paul Emery, Maria W. Greenwald, Maxime Dougados, Richard A. Furie, Mark C. Genovese, Edward C. Keystone et al. "Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks." Arthritis & Rheumatism 54, no. 9 (2006): 2793–2806. doi:10.1002/art.22025
  • Smolen, Josef S., Daniel Aletaha, Johannes WJ Bijlsma, Ferdinand C. Breedveld, Dimitrios Boumpas, Gerd Burmester, Bernard Combe et al. "Treating rheumatoid arthritis to target: recommendations of an international task force." Annals of the rheumatic diseases 69, no. 4 (2010): 631–637. doi:10.1136/ard.2009.123919
  • Aletaha, Daniel, Tuhina Neogi, Alan J. Silman, Julia Funovits, David T. Felson, Clifton O. Bingham III, Neal S. Birnbaum et al. "2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative." Arthritis & rheumatism 62, no. 9 (2010): 2569–2581. doi:10.1002/art.27584
  • Smolen, Josef S., Robert Landewé, Ferdinand C. Breedveld, Maya Buch, Gerd Burmester, Maxime Dougados, Paul Emery et al. "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update." Annals of the rheumatic diseases 73, no. 3 (2014): 492–509. doi:10.1136/annrheumdis-2013-204573
  • Smolen, Josef S., Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, Jackie Nam et al. "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update." Annals of the rheumatic diseases 76, no. 6 (2017): 960–977. doi:10.1136/annrheumdis-2016-210715

References
  1. https://www.wiesbaden.de/medien-zentral/dok/leben/stadtportrait/CV_Paul_Emery.PDF
  2. Quinn, Richard (2012-08-08). "Educational Leader Honored with Top Rheumatology Award".
  3. "Rheumatoid arthritis and switching TNFis: an interview with Professor Paul Emery, University of Leeds". News-Medical.net. 2014-03-12. Retrieved 2023-10-07.
  4. "Paul Emery". The Lancet. 358 (9280). 11 August 2001. doi:10.1016/S0140-6736(01)05618-5.
  5. "Paul Emery". rheumatology.medicinematters.com. Retrieved 2023-10-07.
  6. "Professor Paul Emery OBE FLSW MA MD FRCP FRCPE FMedSci MACR". Leeds Biomedical Research Centre. Retrieved 2023-10-07.
  7. "Publication Analysis 1997–2008: Rheumatology" (PDF). Lab Times. p. 52. Archived from the original (PDF) on 11 July 2017.
  8. Gardner, Joshua (2011-03-17). "Prof Emery most highly cited European rheumatologist". Leeds Biomedical Research Centre. Retrieved 2023-10-07.
  9. Boyack, Kevin W.; Klavans, Richard; Sorensen, Aaron A.; Ioannidis, John P.A. (December 2013). "A list of highly influential biomedical researchers, 1996–2011". European Journal of Clinical Investigation. 43 (12): 1339–1365. doi:10.1111/eci.12171. ISSN 0014-2972.
  10. https://www.youtube.com/watch?v=-pzxyWMs7tc
  11. "Professor Paul Emery | The Academy of Medical Sciences". acmedsci.ac.uk. Retrieved 2023-10-25.
  12. Gransalke, Kathleen. "Rheumatology Publication Analysis 2007-2013". Lab Times. Archived from the original on 16 October 2017. The most-cited papers in rheumatology research, mentioned earlier, already give us a clue about our highly-cited rheumatologists' favourite research subject. That's right: rheumatoid arthritis. Not less than 24 of our top 30 researchers work exclusively or primarily on this disease. The ranking's number one, Paul Emery, is no exception. In his research, he wants to elucidate RA's immunopathogenesis and immunotherapy. In addition, he studies spondyloarthritis, another rheumatoid inflammatory disease, which can cause the fusion of spinal vertebrae, leading to stiffness and inflexibility.
  13. "Rheumatology Publication Analysis 2007–2013: The Most Cited Authors". Lab Times. January 2017. Archived from the original on 23 July 2017.
  14. https://assets.publishing.service.gov.uk/media/5b43959fed915d39d27ad56c/BirthdayHonoursList2018CSVfinal__1_.csv
  15. Wales, The Learned Society of. "Paul Emery". The Learned Society of Wales. Retrieved 2023-10-07.

Notes
  1. He was a Head boy at Cardiff High School
  2. Head of Rheumatology Unit
  3. Senior Lecturer Rheumatology
  4. Arthritis Research UK Professor of Rheumatology
  5. Lead Clinician Rheumatology (1997-2005), Clinical Director Rheumatology (2000- 2018), Director of the Leeds Musculoskeletal Biomedical Research Centre 2008-2022
  6. "In honour of his outstanding innovative research work in the field of rheumatology"
  7. According to Thompson Reuters
  8. According to Web of Science
  9. formerly "Arthritis Research Campaign Professor"
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.